Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ranade, US
Aditya Ranade, Natick, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110244241 | ADHESION IN ECTFE/POLYESTER CO-EXTRUDED STRUCTURES USING TIE LAYERS - The invention describes coextruded multi-layer films comprising a first fluoropolymer layer; a second layer comprising a glycidyl acrylate or glycidyl methacrylate or mixtures thereof adhered to the first layer; and a third layer comprising a polyester or polycarbonate adhered to the second layer. | 10-06-2011 |
Aditya P. Ranade, Natick, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090162652 | CO-EXTRUDED FLUOROPOLYMER MULTILAYER LAMINATES - The invention describes novel multi-layer films with a first outer layer comprising a fluoropolymer; a second interior layer comprising a polyester or a polycarbonate (or combinations thereof) and an acrylic or methacrylic compatibilizer or an alkyl tin oxide as a compatibilizer; and a third outer layer comprising a fluoropolymer or a polyolefin melt adhesive prepared by a coextrusion process. | 06-25-2009 |
Alpana Ranade, Evanston, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100092747 | INFRARED-REFLECTING FILMS AND METHOD FOR MAKING THE SAME - There is provided single layer infrared-reflecting films and a method of making the same that provide enhanced reflectivity in an 800 nanometer to 2500 nanometer infrared waveband. The method comprises providing a substrate, depositing onto the substrate a mixture of an oxide matrix material and either a conductive metal dopant or a higher valence cation, and producing the infrared-reflecting film. | 04-15-2010 |
Aniruddna S. Ranade, Auburn Hills, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20080290674 | HEAD LAMP LOW SPEED COLLISION PROTECTOR - A system for protecting a head tamp of a motor vehicle. The system includes at least one headlamp protector device. The at least one headlamp protector device is adapted to be coupled to a bumper beam and adapted to be coupled to a crush can. The at least one headlamp protector device extends beyond the end of the bumper beam to protect the head lamp during an impact event. | 11-27-2008 |
Bhushan Ranade, Hillsborough, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110083619 | DUAL ENHANCED TUBE FOR VAPOR GENERATOR - A heat exchange assembly for generating steam from a second medium to be used to drive a steam turbine for generating electricity or for other process, includes a tube having a longitudinal axis and an inner wall and an outer wall. The outer wall includes a plurality of spaced fins oriented generally perpendicular to the longitudinal axis. The inner wall defines a preheat zone and a dual phase zone. The preheat zone defines a helical rib configured to provide swirling motion and increase heat transfer surface area to liquid entering the tube increasing heat transfer from the tube to the liquid. The dual phase zone is spaced from the preheat zone and defines a helical rib configured to provide swirling motion to steam and liquid passing through the dual phase zone increasing heat transfer from the tube to the steam and liquid while preventing vapor stagnation and film boiling. | 04-14-2011 |
Gireeja V. Ranade, Berkeley, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080287812 | Systems and Methods for Model-Based Estimation of Cardiac Output and Total Peripheral Resistance - The methods and systems for estimating cardiac output and total peripheral resistance include observing arterial blood pressure waveforms to determine intra-beat and inter-beat variability in arterial blood pressure and estimating from the variability a time constant for a lumped parameter beat-to-beat averaged Windkessel model of the arterial tree. Uncalibrated cardiac output and uncalibrated total peripheral resistance may then be calculated from the time constant. Calibrated cardiac output and calibrated total peripheral resistance may be computed using calibration data, assuming an arterial compliance that is either constant or dependent on mean arterial blood pressure. The parameters of the arterial compliance may be estimated in a least-squares manner. | 11-20-2008 |
Jaydeep V. Ranade, Cupertino, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120178503 | RESONATING ELEMENT FOR REDUCING RADIO-FREQUENCY INTERFERENCE IN AN ELECTRONIC DEVICE - An electronic device may be provided with a display and wireless circuits. The wireless circuits may include antenna structures and radio-frequency transceiver circuitry that transmits and receives radio-frequency signals using the antenna structures. A ground plane for the antenna structures may be located in the center of the electronic device under the display. A resonating element may be used to reduce signal interference that otherwise arises when simultaneously operating the display and the antenna structures. The resonating element may be implemented using an L-shaped structure have an arm that extends parallel to one of the edges of the display. | 07-12-2012 |
Koustubh Ranade, Princeton, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20090117535 | Method for identifying HIV-1 protease inhibitors with reduced metabolic affects - The invention provides a novel in vitro method for identifying HIV-1 protease inhibitors with reduced potential for inducing metabolic abnormalities. The invention further provides diagnostic methods for identifying patients who may be at risk of developing metabolic abnormalities subsequent to the administration of an HIV-1 protease inhibitor. The invention also provides novel polynucleotides associated with the incidence of HIV-1 protease inhibitor induced metabolic abnormalities. The invention also provides polynucleotide fragments corresponding to the genomic and/or coding regions of these polynucleotides which comprise at least one polymorphic locus per fragment. Allele-specific primers and probes which hybridize to these regions, and/or which comprise at least one polymorphic locus are also provided. The polynucleotides, primers, and probes of the present invention are useful in phenotype correlations, medicine, and genetic analysis. The invention further relates to diagnostic methods for using these novel polynucleotides in the diagnosis, treatment, and/or prevention of HIV-1 protease inhibitor induced metabolic abnormalities. | 05-07-2009 |
| 20090202994 | Human single nucleotide polymorphisms in ion channels and other proteins - The invention provides polynucleotide fragments corresponding to the genomic and/or coding regions of these genes which comprise at least one polymorphic site per fragment. Allele-specific primers and probes that hybridize to these regions, and/or that comprise at least one polymorphic site are also provided. The polynucleotides, primers, and probes of the present invention are useful in phenotype correlations, paternity testing, medicine, and genetic analysis. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders, particularly cardiovascular diseases related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention. | 08-13-2009 |
| 20100190172 | GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF - The present invention is based on the discovery of genetic polymorphisms that are associated with cardiovascular disorders, particularly acute coronary events such as myocardial infarction and stroke, and genetic polymorphisms that are associated with responsiveness of an individual to treatment of cardiovascular disorders with statin. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection. | 07-29-2010 |
| 20110152340 | Methods for Identifying Subjects With an Increased Likelihood of Responding to DPP-IV Inhibitors - The invention provides novel in vitro diagnostic methods for identifying subjects or patients who may have an increased likelihood of responding to DPP-IV inhibitor therapy. The invention also provides novel polynucleotides associated with increased responsiveness of a patient to DPP-IV inhibition. Polynucleotide fragments which comprise at least one polymorphic locus, are also provided. Allele-specific primers and probes which hybridize to these polymorphic regions, and/or which comprise at least one polymorphic locus are also provided. The polynucleotides, primers, and probes of the invention are useful in phenotype correlations, medicine, and genetic analysis. | 06-23-2011 |
Manish Ranade, Sunnyvale, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120084657 | PROVIDING CONTENT TO A USER FROM MULTIPLE SOURCES BASED ON INTEREST TAG(S) THAT ARE INCLUDED IN AN INTEREST CLOUD - Techniques are described herein for providing content to a user from multiple sources based on interest tag(s) that are included in an interest cloud. An interest cloud is a tag cloud that includes interest tags, which correspond to respective interests of a user. An interest of a user is subject matter that is deemed to have a greater importance than other subject matter to the user based on information that pertains to the user. For example, an interest of a user may be derived from information in the user's emails, social update streams, web browsing history, a content element that is selected by the user, content that is received from a source that is selected by the user, etc. In another example, a user may designate subject matter as being an interest of the user. | 04-05-2012 |
Rahul A. Ranade, Emerson, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100266648 | Cosmetic Compositions for Imparting Superhydrophobic Films - Compositions and methods are disclosed for imparting super-hydrophobic properties to cosmetics, which can be used to significantly improve water repellency compared to traditional cosmetics. The compositions comprise a hydrophobic film former, and hydrophobic particles, in an emulsion base. | 10-21-2010 |
| 20110008401 | Cosmetic Compositions For Imparting Superhydrophobic Films - Compositions and methods are disclosed for imparting super-hydrophobic properties to cosmetics, in particular mascaras. The compositions comprise a hydrophobic film former in combination with hydrophobically-modified iron oxide pigments and/or carbon black. | 01-13-2011 |
| 20110070180 | Compositions for Imparting Superhydrophobicity - Compositions and methods are disclosed for imparting water repellency to the hair. The compositions generally comprise a first hydrophobic particulate material having a coefficient of dynamic friction of 0.5 or greater in combination with a second hydrophobic particulate material having a coefficient of dynamic friction less than 0.5. | 03-24-2011 |
Rahul A. Ranade, Hillburn, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090175915 | Nanoparticle Compositions Providing Enhanced Color for Cosmetic Formulations - The present invention relates to cosmetic, dermatological, and pharmaceutical compositions that deliver, in an acceptable vehicle or carrier comprising a film former or wax and an effective amount of nanoparticles and one or more pigments and methods for improving the appearance of a biological surface by altering the optical properties of the biological surface. The compositions of the invention enhance color and may be topically applied to the biological surface in an amount effective in improving the aesthetic and natural appearance of the biological surface. | 07-09-2009 |
Rahul A. Ranade, Morristown, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100251932 | SELF-DISPERSING PARTICLES AND METHODS FOR MAKING AND USING THE SAME - A method of modifying a particle that includes reacting a reactive compound having an X—[Y] | 10-07-2010 |
| 20110067720 | Compositions for Imparting Hydrophobicity and Water Repellency to Hair - Compositions and methods are disclosed for imparting water repellency to the hair. The compositions generally comprise a first hydrophobic particulate material having a coefficient of dynamic friction of 0.5 or greater in combination with a second hydrophobic particulate material having a coefficient of dynamic friction less than 0.5. | 03-24-2011 |
Ravi Ranade, Ann Arbor, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20130012625 | STRAIN HARDENING BRITTLE MATRIX COMPOSITES WITH HIGH STRENGTH AND HIGH TENSILE DUCTILITY - A new class of ultra-high performance concrete with very high strength and very high tensile ductility (High Strength High Ductility Concrete) is provided that represents the culmination of two high performance cement-based composite systems, namely those of very high strength, and those of very high tensile ductility into a single composite system. The integration of high strength and ductility has been attained via the adoption of micromechanical analysis and design of fiber reinforced brittle matrix composites. In doing so, the new High Strength High Ductility Concrete material dramatically increases the energy absorption capabilities of structural systems employing this material, making it a very good candidate material where hurricanes, earthquake, impact and blast loads are a concern. | 01-10-2013 |
Sandeep Ranade, San Jose, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120089579 | COMPRESSION PIPELINE FOR STORING DATA IN A STORAGE CLOUD - A cloud storage appliance separates a point-in-time copy of a storage system into payload data chunks and metadata data chunks. The cloud storage appliance identifies a plurality of payload data chunks that have not been saved to a storage cloud. The cloud storage appliance compresses the plurality of payload data chunks. The cloud storage appliance groups the plurality of compressed payload data chunks into one or more cloud files, wherein each of the one or more cloud files is formatted for storage on the storage cloud. The cloud storage appliance then sends the one or more cloud files to the storage cloud. | 04-12-2012 |
| 20120089775 | METHOD AND APPARATUS FOR SELECTING REFERENCES TO USE IN DATA COMPRESSION - A cloud storage appliance generates a plurality of fingerprints of a data chunk, wherein each of the plurality of fingerprints is associated with a different region of the data chunks. The cloud storage appliance identifies a plurality of reference chunks based on the plurality of fingerprints, and generates a plurality of reference chunk pairs. The cloud storage appliance then selects a reference chunk pair based on a probability that an amount of regions of the data chunk match a reference chunk in the reference chunk pair. The selected reference chunk pair will be used to compress the data chunk. | 04-12-2012 |
| 20120089781 | MECHANISM FOR RETRIEVING COMPRESSED DATA FROM A STORAGE CLOUD - A cloud storage appliance receives one or more read requests for data stored in a storage cloud. The cloud storage appliance determines, for a time period, a total amount of bandwidth that will be used to retrieve the requested data from the storage cloud. The cloud storage appliance then determines an amount of remaining bandwidth for the time period. The cloud storage appliance retrieves the requested data from the storage cloud in the time period to satisfy the one or more read requests. The cloud storage appliance additionally retrieves a quantity of unrequested data from the storage cloud in the time period, wherein the quantity of retrieved unrequested data is based on the amount of remaining bandwidth for the time period. | 04-12-2012 |
Shrikant Ranade, Campbell, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090177818 | DISCOVERY OF ELECTRONIC DEVICES UTILIZING A CONTROL BUS - Discovery of electronic devices utilizing a control bus. An embodiment of a method includes connecting a receiving device to a cable, where the cable includes a control bus. If the receiving device is in a disconnect state and a signal from a transmitting device is detected on the control bus, the device is transferred to a state for a first type of transmitting device. If the receiving device is in either the disconnect state or the state for the first type of transmitting device and a predetermined voltage signal is received from the transmitting device, then the receiving device is transferred to a state for a second type of transmitting device. | 07-09-2009 |
| 20090177820 | CONTROL BUS FOR CONNECTION OF ELECTRONIC DEVICES - A method and apparatus for a control bus for connection of electronic devices. An embodiment of a method includes coupling a transmitting device to a receiving device, including connecting a control bus between the transmitting device and the receiving device, with the control bus being a bi-directional, single-line bus. The method further includes obtaining control of the control bus for either the transmitting device or the receiving device, with the device obtaining control becoming an initiator and the other device becoming a follower. One or more control signals are converted to one or more data packets, with each of the one or more control signals representing one of multiple different types of control signals. The generated data packets are transmitted from the initiator to the follower via the control bus. | 07-09-2009 |
| 20100100200 | DISCOVERY OF CONNECTIONS UTILIZING A CONTROL BUS - Discovery of connections utilizing a control bus. An embodiment of a method includes detecting a transition of a control bus from a high state to a low state by a source device, the source device being configured to be coupled with a sink device via an interface, the interface including the control bus, the source device including a pullup device and the sink device including a pulldown device;pulsing the control bus to a high state at the source device; and upon detecting by the source device that the control bus remains in the high state ceasing the pulsing of the control bus to the high state, and transitioning the source device from a disconnected state to a connected state. | 04-22-2010 |
| 20100109795 | TRANSMISSION OF ALTERNATIVE CONTENT OVER STANDARD DEVICE CONNECTORS - Transmission of alternative content over standard device connectors. An embodiment of a method includes connecting a first device to a second device utilizing a standard connector, the connector including multiple pins, and detecting whether the second device is operating in a standard mode or an alternative mode. If the second device is operating in the alternative mode, then switching one or more pins of the standard connector for the alternative mode and transmitting or receiving signals for the alternative mode via the plurality of pins of the standard connector. | 05-06-2010 |
| 20120005377 | DETECTION OF CABLE CONNECTIONS FOR ELECTRONIC DEVICES - Embodiments of the invention are generally directed to detection of cable connections for electronic devices. An embodiment of an apparatus includes a port for the connection of a cable, the port being compatible with a first protocol and a second protocol, the port including multiple pins including a first pin for a first line and a second pin for a second line. The apparatus further includes a processor to determine a type of source device connected to the cable, where determination of the type of source device includes the apparatus detecting a low signal on the first line and a high signal on the second line, and, upon detecting the low signal on first line and the high signal on the second line, the apparatus initiates a discovery sequence, the discovery sequence including transmitting a signal sequence on the second line and attempting to receive the signal sequence on the second line. If the signal sequence is successfully received on the second line, the apparatus determines that a source device compatible with the first protocol is connected to the cable. | 01-05-2012 |
Shrikant Ranade, Irving, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120265581 | System and Method for Multi-Enterprise Supply Chain Optimization - A method of optimizing multi-enterprise supply chain agreements using an electronic scenario based option contract includes creating at a buyer computer a plurality of scenarios of forecasted demand for one or more products and communicating from the buyer computer to a seller computer an offer to enter into an option contract for the supply of the one or more products, the option contract including an option corresponding to each of the plurality of scenarios of forecasted demand. The method further includes executing the option contract, receiving at the buyer computer an indication of current buyer demand for at least one scenario associated with the one or more products, and exercising at least a portion of the option in the option contract based at least in part on the indicated buyer demand. | 10-18-2012 |
Shrirang V. Ranade, Arlington, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090098176 | MEDICAL DEVICES WITH TRIGGERABLE BIOADHESIVE MATERIAL - Described herein are implantable medical devices comprising a biocompatible polymer comprising a triggerable bioadhesive property that allows the device to adhere to body tissue. The triggerable bioadhesive property of the polymer can be triggered or activated by exposure to a stimulus. Also, the present invention pertains to methods of making an implantable medical device comprising a biocompatible polymer comprising a triggerable bioadhesive property that allows the device to adhere to body tissue. | 04-16-2009 |
| 20100098741 | METHOD OF INCORPORATING CARBON NANOTUBES IN A MEDICAL APPLIANCE, A CARBON NANOTUBE MEDICAL APPLIANCE, AND A MEDICAL APPLIANCE COATED USING CARBON NANOTUBE TECHNOLOGY - A method of coating an article is provided. The method includes: preparing a solution including a bioactive agent and a carbon nanotube precursor; treating the solution to form carbon nanotubes; and applying the solution to the article. A method of producing a medical device is provided. The method includes: forming a core of the medical device with a pattern on a surface of the core and assembling a multi-walled carbon nanotube array on the pattern on the surface. The pattern on the surface may determine an orientation of the multi-walled carbon nanotube array. A method of manufacturing a medical appliance is provided. The method includes creating a mixture of a carbon nanotube precursor and a polymer and injecting the mixture into a mold. The mold forms the mixture into a shape of the medical appliance. A method of forming a nanotube tissue scaffold is provided. The method includes forming a nanotube precursor and treating the nanotube precursor to form the nanotube tissue scaffold. The nanotube tissue scaffold is electrically conductive. | 04-22-2010 |
| 20110014264 | Medical Devices Having Nanostructured Regions For Controlled Tissue Biocompatibility And Drug Delivery - According to certain aspects of the invention, implantable or insertable medical devices are provided that contain one or more nanoporous regions, which may further comprise interconnected nanopores. Other aspects of the invention are directed to implantable or insertable medical devices that contain one or more nanostructured regions, which are formed by a variety of methods. Still other aspects of the invention are directed to implantable or insertable medical devices having nanotextured surface regions, in which cell-adhesion-promoting biomolecules (e.g., glycosaminoglycans, proteoglycans, cell adhesion peptides, and adhesive proteins) are provided on, within or beneath the nanotextured surface regions. | 01-20-2011 |
| 20110150972 | MEDICAL DEVICES HAVING IMPROVED PERFORMANCE - According to an aspect of the present invention, medical devices are provided that contain at least one polymeric region which contains (a) at least one block copolymer that contains at least at least three polymer blocks that differ from one another and (b) at least one therapeutic agent. | 06-23-2011 |
Swati Ranade, Foster City, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120196279 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID SAMPLE PREPARATION - Provided are methods and compositions for the production of double-stranded nucleic acids, which can optionally be used as templates in high-throughput sequencing systems. In certain embodiments, these templates do not require exogenous primers to facilitate initiation of polymerase-dependent nascent strand synthesis. In certain embodiments, these templates comprise a single-stranded or gapped region that serves as a polymerase priming site. | 08-02-2012 |
Swati S. Ranade, San Mateo, CA US
Vasant V. Ranade, Libertyville, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20080255229 | Parenteral solution containing amiodarone in NNDMA (N,N,-Dimethylacetamide) - Disclosed herein are parenteral solutions containing 3-diethylaminoethoxy benzoyl-benzofurans, such as amiodarone, in a diluent NNDMA (N,N-Dimethylacetamide) useful in the treatment of cardiac arrhythmias both supraventricular, ventricular as well as, the condition of cardiac arrest. | 10-16-2008 |
| 20090060894 | Treatment to aid in the metabolism of alcohol - Alcohol intoxication is a serious problem. Many individuals are more sensitive to alcohol intoxication and placed at a decided disadvantage in social drinking situations. What is proposed is a way to facilitate alcohol metabolism in individuals who have consumed alcohol by the administration of enzymes to speed the alcohols metabolism. | 03-05-2009 |
| 20090233951 | Parenteral solutions containing metolazone - Disclosed herein are parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamide in N,N-dimethylactamide, polyethylene glycol and D | 09-17-2009 |
| 20100010096 | Methadone chiral isolate as an improved pharmaceutical - Methadone is a frequently employed agent for the treatment of drug addiction and the treatment of pain. Methadone prolongs the cardiac action potential, which on the surface electrocardiogram is represented by QT prolongation. This QT prolongation is known to increase the risk for the development of cardiac arrhythmias, especially the form of ventricular tachycardia known as Torsade de Pointes. For this reason, the FDA has inserted a “black box” warning for potential life threatening arrhythmias. The invention described in this application is the surprising finding that the R-isomer of methadone causes less inhibition of the potassium channel, IKr and thus would have less of a chance of causing life threatening arrhythmias. What is claimed is a method of chirally separating methadone with one isomer having less QT prolongation and more analgesic action that would make a superior pharmacologic agent than the racemate R,S methadone. | 01-14-2010 |
| 20100029577 | Chiral separation, characterization and biological action of optically active isomers of digoxin - Disclosed herein is the method for separation of enantiomers or isomers of digoxin. These isomers are to be used-in the treatment of heart failure without adverse or unneeded cardiac actions in humans. Additionally what is claimed is an isolate with less or no cardiac contractile effect but with AV node slowing such that the composition would be an effective therapy for the control of the ventricular response in atrial fibrillation. Also disclosed are methods for assaying these isomeric compounds present in biological fluids to enable the separation of pharmacologic actions. | 02-04-2010 |
| 20100173875 | Formulation of aspirin that is stable and showing minimal hydrolysis for parenteral adminstration for the treatment of cardiovascular and other disease states - Disclosed herein are ways to solubilize aspirin for parenteral administration containing aspirin and a diluent NNDMA (N,N-Dimethylacetamide) useful in the treatment of acute coronary syndromes as well as other disease states. The solution so constituted is stable at room temperature for prolonged periods without decomposition and avoids significant hydrolysis of the aspirin and thus the loss of the anti-platelet action when stored. | 07-08-2010 |
Vasant V. Ranade, Lake Bluff, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20120004256 | PARENTERAL FORMULATION OF CLOPIDOGREL - Described herein are ways to solubilize clopidogrel for parenteral administration containing clopidogrel and a diluent NNDMA (N,N-dimethylacetamide); useful in the prevention of platelet aggregation in acute coronary syndrome, acute myocardial infarction or to prevent platelet facilitated thrombosis following coronary angioplasty and/or coronary stenting. | 01-05-2012 |
| 20120077829 | PARENTERAL SOLUTIONS CONTAINING METOLAZONE - Disclosed herein are parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamide in N,N-dimethylactamide, polyethylene glycol and D | 03-29-2012 |
Vassant V. Ranade US
| Patent application number | Description | Published |
|---|---|---|
| 20090325918 | Synthesis and separation of optically active isomers and cyclopropyl derivatives of spironolactone and their biological action - Methods for separation and synthesis of the optically active 7-thioester isomers and mono or bis-cyclopropyl derivatives of spironolactone are provided. Preferred stereoisomerically purified 7-thioester isomers and mono or bis-cyclopropyl derivatives of spironolactone have fewer effects mediated by gonadal steroid receptors relative to effect mediated by minteralocorticoid progesterone receptors, compared to the stereoisomerically unpurified form of the compound. These optically active compounds can be useful for obtaining reduction in moderate essential hypertension and it the treatment of congestive heart failure in humans with minimized undesirable side effects such as gynecomastia, tender breast enlargement and menstrual irregularities in women, and loss of libido in men. | 12-31-2009 |
Vinayak V. Ranade, Somerville, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20130024404 | FLIGHT CACHING METHODS AND APPARATUS - According to some aspects, a system is provided comprising at least one computer readable storage medium storing a cache of flight information comprising a plurality of flight solutions, the cache capable of being accessed to obtain flight solutions that meet a criteria specified in one or more flight search queries, and at least one computer programmed to apply at least one machine learning model to at least some of the flight information in the flight information cache to classify at least one of the plurality of flight solutions according to an assessed fidelity of the at least one flight solution, and perform at least one action based on the classified at least one flight solution. | 01-24-2013 |